Return to Home Incidence > Table > Interpret

Interpretation of Incidence Rates Data

Incidence Rate Report by State

Non-Hodgkin Lymphoma (All Stages^), 2018-2022

All Races (includes Hispanic), Both Sexes, All Ages

Sorted by Rate

Explanation of Column Headers
Incidence Rate (95% Confidence Interval) - The incidence rate is based upon 100,000 people and is an annual rate (or average annual rate) based on the time period indicated. Rates are age-adjusted by 5-year age groups to the 2000 U.S. standard million population.

Recent Trends - This is an interpretation of the AAPC/APC:

AAPC/APC (95% Confidence Interval) - the change in rate over time


Other Notes


Line by Line Interpretation of the Report


US (SEER+NPCR)1


Puerto Rico2


New Mexico7


Alabama2


Nevada2


Hawaii7


Arizona2


District of Columbia2


South Carolina2


Wyoming2


Mississippi2


Virginia2


Colorado2


Tennessee2


Georgia7


Maryland2


Oklahoma2


Montana2


Delaware2


Texas7


Oregon2


Arkansas2


North Carolina2


California7


Indiana2


Alaska2


Massachusetts2


Utah7


Rhode Island2


Michigan2


North Dakota2


Nebraska2


Idaho7


Louisiana7


Kansas2


Illinois7


Pennsylvania2


South Dakota2


Ohio2


Missouri2


Washington1


Vermont2


West Virginia2


Maine2


Kentucky7


New Hampshire2


New York7


Wisconsin2


New Jersey7


Connecticut7


Florida2


Iowa7


Minnesota2





Notes:
Created by statecancerprofiles.cancer.gov on 03/21/2026 8:32 pm.

State Cancer Registries may provide more current or more local data.

† Incidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population (SEER areas use 20 age groups and NPCR areas use 19 age groups). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Rates calculated using SEER*Stat. Population counts for denominators are based on Census populations as modified by NCI. The US Population Data File is used for SEER and NPCR incidence rates.

Rates and trends are computed using different standards for malignancy. For more information see malignant.html.

^ All Stages refers to any stage. Due to changes in stage coding, Combined Summary Stage with Expanded Regional Codes (2004+) is used for data from Surveillance, Epidemiology, and End Results (SEER) databases and Merged Summary Stage is used for data from National Program of Cancer Registries databases. Due to the increased complexity with staging, other staging variables maybe used if necessary.

Source: SEER and NPCR data. For more specific information please see the table.

Data for United States does not include Puerto Rico.